EUnetHTA Joint Action is taking forward the scientific recommendations from the Pharmaceutical Forum Working Group on Relative Effectiveness of Pharmaceuticals through the work performed in the EUnetHTA JA Work Package 5 (Relative Effectiveness Assessment of Pharmaceuticals). It is not a continuation of the Pharmaceutical Forum in terms of its structural/governance organisation.

A joint assessment is structured information for rapid or full HTAs which is the output of joint production in which 2 or more countries and/or organisations work together to prepare shared products or agreed outcomes. Read more.

Access is currently restricted to EUnetHTA Partners and Associates who contribute to the POP database by providing information about their planned and ongoing projects at least quarterly.
Among participating EUnetHTA partners, access is available to persons who work for EUnetHTA Partner or Associates. The number of users from each agency is not limited.

Health technology is the application of scientific knowledge in health care and prevention.

Health technology assessment (HTA) is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient focused and seek to achieve best value.

Despite its policy goals, HTA must always be firmly rooted in research and the scientific method.

Examples of Health Technology

  • Diagnostic and treatment methods
  • Medical equipment
  • Pharmaceuticals
  • Rehabilitation and prevention methods
  • Organisational and supportive systems within which health care is provided
Syndicate content